ArticleCancer chemotherapy and pharmacology2023

The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer.

Cathrine F Hjorth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.